These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9034754)

  • 1. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C.
    Amtmann E
    Drugs Exp Clin Res; 1996; 22(6):287-94. PubMed ID: 9034754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
    Singh AT; Radeff JM; Kunnel JG; Stern PH
    Biochim Biophys Acta; 2000 Sep; 1487(2-3):201-8. PubMed ID: 11018472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor Tricyclodecan-9-yl-xanthate (D609).
    Girón-Calle J; Srivatsa K; Forman HJ
    J Pharmacol Exp Ther; 2002 Apr; 301(1):87-94. PubMed ID: 11907161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and phospholipase C inhibitory activity of D609 diastereomers.
    González-Roura A; Casas J; Llebaria A
    Lipids; 2002 Apr; 37(4):401-6. PubMed ID: 12030321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells.
    Larsen EC; Hatcher JF; Adibhatla RM
    Neuroscience; 2007 May; 146(3):946-61. PubMed ID: 17434680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D609, an inhibitor of phosphatidylcholine-specific phospholipase C, inhibits group IV cytosolic phospholipase A2.
    Kang MS; Jung SY; Jung KM; Kim SK; Ahn KH; Kim DK
    Mol Cells; 2008 Nov; 26(5):481-5. PubMed ID: 18688177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reaction.
    Müller-Decker K
    Biochem Biophys Res Commun; 1989 Jul; 162(1):198-205. PubMed ID: 2751648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
    Abalsamo L; Spadaro F; Bozzuto G; Paris L; Cecchetti S; Lugini L; Iorio E; Molinari A; Ramoni C; Podo F
    Breast Cancer Res; 2012 Mar; 14(2):R50. PubMed ID: 22429397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.
    Adibhatla RM; Hatcher JF; Gusain A
    Neurochem Res; 2012 Apr; 37(4):671-9. PubMed ID: 22101393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D609-sensitive tyrosine phosphorylation is involved in Fas-mediated phospholipase D activation.
    Kim JG; Shin I; Lee KS; Han JS
    Exp Mol Med; 2001 Dec; 33(4):303-9. PubMed ID: 11795496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane A2 receptor-mediated tonic contraction is attributed to an activation of phosphatidylcholine-specific phospholipase C in rabbit aortic smooth muscles.
    Nakahata N; Takano H; Ohizumi Y
    Life Sci; 2000; 66(5):PL 71-6. PubMed ID: 10670835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D609 inhibits progression of preexisting atheroma and promotes lesion stability in apolipoprotein e-/- mice: a role of phosphatidylcholine-specific phospholipase in atherosclerosis.
    Zhang L; Zhao J; Su L; Huang B; Wang L; Su H; Zhang Y; Zhang S; Miao J
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):411-8. PubMed ID: 20139365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylcholine-specific phospholipase C and D in stimulation of RAW264.7 mouse macrophage-like cells by lipopolysaccharide.
    Zhang F; Zhao G; Dong Z
    Int Immunopharmacol; 2001 Jul; 1(7):1375-84. PubMed ID: 11460317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D609-phosphatidylcholine-specific phospholipase C inhibitor attenuates thapsigargin-induced sodium influx in human lymphocytes.
    Nofer JR; Junker R; Seedorf U; Assmann G; Zidek W; Tepel M
    Cell Signal; 2000 May; 12(5):289-96. PubMed ID: 10822169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis.
    Kiss Z; Tomono M
    Biochim Biophys Acta; 1995 Oct; 1259(1):105-8. PubMed ID: 7492608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compound tricyclodecan-9-yl-xanthogenate (D609).
    Kiss Z; Crilly KS; Chung T
    Biochem Pharmacol; 1998 Mar; 55(6):915-8. PubMed ID: 9586966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells.
    Spadaro F; Ramoni C; Mezzanzanica D; Miotti S; Alberti P; Cecchetti S; Iorio E; Dolo V; Canevari S; Podo F
    Cancer Res; 2008 Aug; 68(16):6541-9. PubMed ID: 18701477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of mouse endotoxin shock by inhibition of phosphatidylcholine-specific phospholipase C.
    Tschaikowsky K; Schmidt J; Meisner M
    J Pharmacol Exp Ther; 1998 May; 285(2):800-4. PubMed ID: 9580629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylmercury-induced toxicity is mediated by enhanced intracellular calcium through activation of phosphatidylcholine-specific phospholipase C.
    Kang MS; Jeong JY; Seo JH; Jeon HJ; Jung KM; Chin MR; Moon CK; Bonventre JV; Jung SY; Kim DK
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):206-15. PubMed ID: 16854443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of apoptosis by inhibition of phosphatidylcholine-specific phospholipase C in vascular endothelial cells.
    Miao JY; Kaji K; Hayashi H; Araki S
    Endothelium; 1997; 5(4):231-9. PubMed ID: 9588815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.